Page last updated: 2024-10-22

alfuzosin and Diabetes Mellitus, Type 2

alfuzosin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

alfuzosin: structure given in first source

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Alfuzosin ameliorated oxidative stress, glycative stress and insulin resistance in HepG2 cells."4.31Alfuzosin ameliorates diabetes by boosting PGK1 activity in diabetic mice. ( Chen, X; Han, L; Hu, Z; Kang, J; Li, C; Li, X; Liu, J; Wu, T; Zhao, W; Zhou, J, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, J1
Wu, T1
Li, C1
Hu, Z1
Han, L1
Li, X1
Liu, J1
Zhao, W1
Kang, J1
Chen, X1

Other Studies

1 other study available for alfuzosin and Diabetes Mellitus, Type 2

ArticleYear
Alfuzosin ameliorates diabetes by boosting PGK1 activity in diabetic mice.
    Life sciences, 2023, Mar-15, Volume: 317

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat;

2023